Pharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY720 after myocardial ischaemia-reperfusion

British Journal of Pharmacology

Volumn 160, Issue 5, 2010, Pages 1243-1251

  Hofmann, U ^a   Hu, K ^a   Walter, F ^a   Burkard, N ^a   Ertl, G ^a   Bauersachs, J ^a   Ritter, O ^a   Frantz, S ^a   Bonz, A ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

FTY720; Ischaemia reperfusion; Sphingosine 1 phosphate

Indexed keywords

FINGOLIMOD; INDO 1; TUMOR NECROSIS FACTOR ALPHA; CALCIUM; PROPANEDIOL DERIVATIVE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; ATTENUATION; BLOOD; CONTROL GROUP; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE TACHYCARDIA; IMMUNOHISTOCHEMISTRY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEUKOPENIA; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; WESTERN BLOTTING; WISTAR RAT; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; HEART ARRHYTHMIA; HEART INFARCTION PREVENTION; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PROCEDURES;

ANIMALS; ARRHYTHMIAS, CARDIAC; CALCIUM; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ISCHEMIC PRECONDITIONING, MYOCARDIAL; LYMPHOCYTE COUNT; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PROPYLENE GLYCOLS; RATS; RATS, WISTAR; RECEPTORS, LYSOSPHINGOLIPID; SPHINGOSINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953200332     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00767.x     Document Type: Article

References (45)

1. Alexander SPH, Mathie A, Peters JA (2009). Guide to Receptors and Channels (GRAC), 4th edn. Br J Pharmacol 158 (Suppl. 1 S1 S254.
2. An S, Goetzl E, Lee H (1998). Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate. J Cell Biochem Suppl 30-31 : 147 157.
3. Anselmo D, Amersi FF, Shen XD, Gao F, Katori M, Ke B et al. (2002). FTY720: a novel approach to the treatment of hepatic ischemia-reperfusion injury. Transplant Proc 34 : 1467 1468.
4. Awad AS, Ye H, Huang L, Li L, Foss FW, MacDonald TL et al. (2006). Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol 290 : F1516 F1524.
5. Bolick D, Srinivasan S, Kim K, Hatley M, Clemens J, Whetzel A (2005). Sphingosine-1-phosphate prevents tumor necrosis factor-alpha-mediated monocyte adhesion to aortic endothelium in mice. Arterioscler Thromb Vasc Biol 25 : 976 981.
6. Brinkmann V (2004). FTY720: mechanism of action and potential benefit in organ transplantation. Yonsei Med J 45 : 991 997.
7. Brinkmann V, Cyster J, Hla T (2004). FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant 4 : 1019 1025.
8. Chiba K, Matsuyuki H, Maeda Y, Sugahara K (2006). Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus. Cell Mol Immunol 3 : 11 19.
9. Dahm F, Nocito A, Bielawska A, Lang KS, Georgiev P, Asmis LM et al. (2006). Distribution and dynamic changes of sphingolipids in blood in response to platelet activation. J Thromb Haemost 4 : 2704 2709.
10. Dantas A, Igarashi J, Michel T (2003). Sphingosine 1-phosphate and control of vascular tone. Am J Physiol Heart Circ Physiol 284 : H2045 H2052.
11. Delbridge MS, Shrestha BM, Raftery AT, El Nahas AM, Haylor JL (2007). Reduction of ischemia-reperfusion injury in the rat kidney by FTY720, a synthetic derivative of sphingosine. Transplantation 84 : 187 195.
12. Dudek S, Camp S, Chiang E, Singleton P, Usatyuk P, Zhao Y et al. (2007). Pulmonary endothelial cell barrier enhancement by FTY720 does not require the S1P1 receptor. Cell Signal 19 : 1754 1764.
13. Egom E, Ke Y, Musa H, Mohamed T, Wang T, Cartwright E et al. (2009). FTY720 prevents ischemia/reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak1/Akt signaling. J Mol Cell Cardiol 48 : 406 414.
14. English D, Brindley D, Spiegel S, Garcia J (2002). Lipid mediators of angiogenesis and the signalling pathways they initiate. Biochim Biophys Acta 1582 : 228 239.
15. Frantz S, Calvillo L, Tillmanns J, Elbing I, Dienesch C, Bischoff H et al. (2005). Repetitive postprandial hyperglycemia increases cardiac ischemia/reperfusion injury: prevention by the a-glucosidase inhibitor acarbose. FASEB J 19 : 2459 2472.
16. Gon Y, Wood MR, Kiosses WB, Jo E, Sanna MG, Chun J et al. (2005). S1P3 receptor-induced reorganization of epithelial tight junctions compromises lung barrier integrity and is potentiated by TNF. Proc Natl Acad Sci USA 102 : 9270 9275.
17. Graler M, Goetzl E (2004). The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J 18 : 551 553.
18. Hofmann U, Burkard N, Vogt C, Thoma A, Frantz S, Ertl G et al. (2009). Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion. Cardiovasc Res 83 : 285 293.
19. Huhn R, Heinen A, Weber N, Hollmann M, Schlack W, Preckel B (2008). Hyperglycaemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore. Br J Anaesth 100 : 465 471.
20. Jongsma M, van Unen J, van Loenen P, Michel M, Peters S, Alewijnse A (2009). Different response patterns of several ligands at the sphingosine-1-phosphate receptor subtype 3 (S1P3). Br J Pharmacol 156 : 1305 1311.
21. Karliner J, Honbo N, Summers K, Gray M, Goetzl E (2001). The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. J Mol Cell Cardiol 33 : 1713 1717.
22. Kaudel CP, Schmiddem U, Frink M, Bergmann S, Pape HC, Krettek C et al. (2006). FTY720 for treatment of ischemia-reperfusion injury following complete renal ischemia in C57/BL6 mice. Transplant Proc 38 : 679 681.
23. Kilic A, Velic A, De Windt L, Fabritz L, Voss M, Mitko D et al. (2005). Enhanced activity of the myocardial Na+/H+ echanger NHE-1 contributes to cardiac remodelling in atrial natriuretic peptide receptor-deficient mice. Circulation 112 : 2307 2311.
24. Landeen L, Dederko D, Kondo C, Hu B, Aroonsakool N, Haga J (2008). Mechanisms of the negative inotropic effects of sphingosine-1-phosphate on adult mouse ventricular myocytes. Am J Heart Circ Physiol 294 : H736 H749.
25. Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S et al. (2009). Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 15 : 192 199.
26. Mansoor M, Melendez AJ (2008). Recent trials for FTY720 (fingolimod): a new generation of immunomodulators structurally similar to sphingosine. Rev Recent Clin Trials 3 : 62 69.
27. Means C, Brown J (2009). Sphingosine-1-phosphate receptor signalling in the heart. Cardiovasc Res 82 : 193 200.
28. Means CK, Xiao CY, Li Z, Zhang T, Omens JH, Ishii I et al. (2007). Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 292 : H2944 H2951.
29. Monteiro RM, Camara NO, Rodrigues MM, Tzelepis F, Damiao MJ, Cenedeze MA et al. (2009). A role for regulatory T cells in renal acute kidney injury. Transpl Immunol 21 : 50 55.
30. Nakajima N, Cavalli A, Biral D, Glembotski C, McDonough P, Ho P et al. (2000). Expression and characterization of Edg-1 receptors in rat cardiomyocytes: calcium deregulation in response to sphingosine 1-phosphate. Eur J Biochem 267 : 5679 5686.
31. Opitz C, Finn P, Pfeffer M, Mitchell G, Pfeffer J (1998). Effects of reperfusion on arrhythmias and death after coronary artery occlusion in the rat: increased electrical stability independent of myocardial salvage. J Am Coll Cardiol 32 : 261 267.
32. Ortiz AM, Troncoso P, Kahan BD (2003). Prevention of renal ischemic reperfusion injury using FTY 720 and ICAM-1 antisense oligonucleotides. Transplant Proc 35 : 1571 1574.
33. Sanchez T, Estrada-Hernandez T, Paik J, Wu M, Venkataraman K, Brinkmann V et al. (2003). Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial growth factor-induced vascular permeability. J Biol Chem 278 : 47281 47290.
34. Sanna M, Liao J, Jo E, Alfonso C, Ahn M, Peterson M (2004). Sphingosine-1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J Biol Chem 279 : 13839 13848.
35. Sano T, Baker D, Virag T, Wada A, Yatomi Y, Kobayashi T et al. (2002). Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood. J Biol Chem 277 : 21197 21206.
36. Schmouder R, Serra D, Wang Y, Kovarik J, DiMarco J, Hunt T (2006). FTY720: placebo-controlled study of the effect on cardiac rate and rhythm in healthy subjects. J Clin Pharmacol 46 : 895 904.
37. Singer II, Tian M, Wickham LA, Lin J, Matheravidathu SS, Forrest MJ et al. (2005). Sphingosine-1-phosphate agonists increase macrophage homing, lymphocyte contacts, and endothelial junctional complex formation in murine lymph nodes. J Immunol 175 : 7151 7161.
38. Spiegel S, Milstien S (2003). Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4 : 397 407.
39. Tao R, Zhang J, Vessey D, Honbo N, Karliner J (2007). Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes. Cardiovasc Res 74 : 56 63.
40. Theilmeier G, Schmidt C, Herrmann J, Keul P, Schafers M, Herrgott I (2006). High-density lipoproteins and their constituent, sphingosine-1- phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 114 : 1403 1409.
41. Tsukada T, Sanna M, Rosen H, Gottlieb R (2007). S1P1-selective agonist SEW2871 exacerbate reperfusion arrhthmias. J Cardiovasc Pharmacol 50 : 660 669.
42. Whetzel A, Bolick D, Srinivasan S, Macdonald T, Morris M, Ley L (2006). Sphingosiene-1-phosphate prevents monocyte/endotheliel interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor. Circ Res 99 : 731 739.
43. Yellon D, Downey J (2003). Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83 : 1113 1151.
44. Zatta A, Kin H, Lee G, Wang N, Jiang R, Lust R et al. (2006). Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling. Cardiovasc Res 70 : 315 324.
45. Zhang J, Honbo N, Goetzl EJ, Chatterjee K, Karliner JS, Gray MO (2007). Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia. Am J Physiol Heart Circ Physiol 293 : H3150 H3158.